Method for detecting cancer using monoclonal antibodies to new mucin epitopes
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 21, 1999
Issued Date -
N/A
app pub date -
Jun 2, 1995
filing date -
Nov 19, 1986
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel hybridoma cell lines producing monoclonal antibodies reactive with purified mucin antigens from normal and tumor sources are generated using mucins, including purified mucins from tumor sources. Epitopes on mucin antigens from normal and tumor sources are demonstrated to be distinct, using these new antibodies. The antibodies may be useful alone or in combination, in the diagnosis and treatment of cancer including malignancies of the breast and lung.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully